Evidence map›Paper›PMID 33551668›Full record

ArticleChemical engineering journal (Lausanne, Switzerland : 1996)2021

Point of care detection of COVID-19: Advancement in biosensing and diagnostic methods.

Shariq Suleman, Sudheesh K Shukla, Nitesh Malhotra, Shikandar D Bukkitgar, Nagaraj P Shetti, Roberto Pilloton, Jagriti Narang, Yen Nee Tan, Tejraj M Aminabhavi

Abstract read
In one paragraph

Article in Chemical engineering journal (Lausanne, Switzerland : 1996), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Electrochemical biosensor detection on respiratory and flaviviruses.Applied microbiology and biotechnology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Recent advances in point of care testing for COVID-19 detection.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shariq SulemanDepartment of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India.
Sudheesh K ShuklaInstitute of Advanced Materials, IAAM. Gammalkilsvagen 18, 590 53, Ulrika, Sweden.
Nitesh MalhotraDepartment of Physiotherapy, Faculty of Applied Health Sciences (FAHS), Manav Rachana International Institute of Research and Studies, Faridabad, Haryana, India.
Shikandar D BukkitgarCenter for Electrochemical Science & Materials, Department of Chemistry, K.L.E. Institute of Technology, Opposite to Airport, Hubballi 580 027, India.
Nagaraj P ShettiCenter for Electrochemical Science & Materials, Department of Chemistry, K.L.E. Institute of Technology, Opposite to Airport, Hubballi 580 027, India.
Roberto PillotonInstitute of Crystallography of National Research Council (IC-CNR), Rome, Italy.
Jagriti NarangDepartment of Biotechnology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India.
Yen Nee TanFaculty of Science, Agriculture and Engineering, Newcastle University, Newcastle Upon Tyne NE1 7RU, United Kingdom.
Tejraj M AminabhaviDepartment of Chemistry, Karnatak University, Dharwad 580 007, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent outbreak of COVID-19 has created much inconvenience and fear that the virus can seriously affect humans, causing health hazards and death. This pandemic has created much worry and as per the report by World Health Organization (WHO), more than 43 million individuals in 215 countries and territories were affected. People around the world are still struggling to overcome the problems associated with this pandemic. Of all the available methods, reverse-transcriptase polymerase chain reaction (RT-PCR) has been widely practiced for the pandemic detection even though several diagnostic tools are available having varying accuracy and sensitivity. The method offers many advantages making it a life-saving tool, but the method has the limitation of transporting to the nearest pathology lab, thus limiting its application in resource limited settings. This has a risen a crucial need for point-of-care devices for on-site detection. In this venture, biosensors have been used, since they can be applied immediately at the point-of-care. This review will discuss about the available diagnostic methods and biosensors for COVID-19 detection.

Indexed as

BiosensorsCoronavirusesCOVID-19DiagnosisPandemicSymptoms

Identifiers

PMID33551668
PMCPMC7847737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.